Medscheme has withdrawn its legal application against Bonitas Medical Fund. The decision clears the way for the Council for Medical Schemes (CMS) to continue a forensic investigation into disputed procurement processes. The legal action concerned contracts for medical scheme administration, managed care, marketing and sales distribution. Medscheme claimed to have evidence of significant irregularities in tender processes involving Bonitas’s BonCap…
Tag: managed care
-
Digital Health Transformation: A New Era of Care
South Africa’s health system is shifting fast. Clinical demand is rising. Patient expectations are changing. Technology is now good enough to remove distance, time and cost from many first points of care. Digitisation is no longer a plan. It is already reshaping care delivery. The real question is governance. Leaders must decide whether to roll out digital health deliberately, fairly,…
-
Momentum Bonitas Deal Impacts Medical Aid Landscape
Momentum’s latest results point to a group that is gaining confidence in a tough insurance market. The standout move is operational, not financial. The Momentum Bonitas Deal means that, from June, Momentum will become the administrator of Bonitas, South Africa’s second-largest open medical aid scheme. It is described as the biggest medical scheme transfer in the country to date. This…
-
Momentum Bonitas Deal Lifts Market Share To 30%
The Momentum Bonitas deal is set to reshape South Africa’s tightly concentrated medical scheme administration market. This follows Momentum Health winning the tender to administer the Bonitas Medical Fund. The transfer takes effect on 1 June 2026. It is being positioned by Momentum as a springboard for further growth in a sector dominated by a handful of large players. Momentum’s…
-
AfroCentric Results Show Revenue Surged Significantly
AfroCentric Investment Corporation has released its financial results for the year ending December. The JSE-listed healthcare giant reported a massive spike in revenue. However, the group also faced a significant basic loss. This was primarily due to heavy asset impairments and strategic business disposals. Massive Revenue Growth For AfroCentric The group’s continuing operations showed exceptional top-line growth. Total revenue climbed…
-
Bonitas Tender Dispute: Court Action and Tender Controversy
South Africa’s second-largest open medical scheme, Bonitas, is opposing an urgent court application by Medscheme to block the appointment of two new service providers. The Bonitas Tender Dispute centres on Bonitas’ decision to end a 44-year administration relationship with Medscheme. Medscheme has served as its administrator since 1982. Bonitas, which covers more than 730,000 people, has appointed Momentum to take…
-
Bonitas Medscheme Split Sees Momentum and PHA Win Contracts
The Bonitas Medscheme Split has become a major topic in the South African healthcare sector. Bonitas Medical Fund, South Africa’s second-largest open medical scheme, has confirmed a major supplier shake-up. It will end its long-running administration relationship with Medscheme and hand key roles to Momentum Health and Private Health Administrators (PHA). The changes cover all Bonitas options except Boncap, its…
-
AfroCentric Divests Activo Health In Strategic Shift Toward Services
AfroCentric Investment Corporation, a Johannesburg Stock Exchange-listed healthcare firm, has announced the sale of its pharmaceutical unit, Activo Health, to Portuguese pharmaceutical giant FHC Group. This sale marks a pivotal shift in AfroCentric’s operational focus. The group is moving away from pharmaceutical manufacturing and marketing. AfroCentric Divests Activo Health In Portfolio Overhaul AfroCentric’s subsidiary, ACT Healthcare Assets, entered into an…